Loading...
Loading...
Browse all stories on DeepNewz
VisitWhich company will be the first to commercialize CiPSC-based treatments for Type 1 diabetes by end of 2024?
Novo Nordisk • 25%
Vertex Pharmaceuticals • 25%
ViaCyte • 25%
Other • 25%
Official company announcements or regulatory filings
Chinese Scientists Cure 25-Year-Old Woman of Type 1 Diabetes Using Stem Cells
Sep 27, 2024, 10:55 AM
Chinese scientists have achieved a groundbreaking clinical cure for a type 1 diabetes patient by transplanting islet cells derived from chemically induced pluripotent stem cells (CiPSC-islets). This procedure, published in the journal Cell, marks the first time a patient has been treated using reprogrammed stem cells extracted from their own body. A 25-year-old woman, who underwent the procedure in June 2023, started producing her own insulin less than three months after doctors injected about 1.5 million stem cell clusters into her abdominal muscles in a 30-minute procedure. She has maintained this insulin production for over a year without the need for supplements.
View original story